We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » USMCA Trade Deal Will Keep U.S. Drug Prices High, Groups Warn
USMCA Trade Deal Will Keep U.S. Drug Prices High, Groups Warn
The Trump administration’s newly negotiated trade deal with Canada and Mexico threatens to keep American drug prices high, two dozen-plus consumer, health, trade and other organizations warned in a letter to the U.S. Trade Representative. The 29 groups — including the Association for Accessible Medicines (AAM) and the AARP — claim some provisions in the proposed NAFTA overhaul are inconsistent with U.S. law.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor